Lennart Hammarstrom

Stockholm, AB 14186, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 219 publications

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 31, 2026

APOBEC2 deficiency disrupts hematopoietic lineage commitment, resulting in emergence of dual identity lymphocytes in mice and humans.

APOBEC2 deficiency disrupts hematopoietic lineage commitment, resulting in emergence of dual identity lymphocytes in mice and humans.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 05, 2026

APOBEC2 deficiency disrupts hematopoietic lineage commitment, resulting in emergence of dual identity lymphocytes in mice and humans.

APOBEC2 deficiency disrupts hematopoietic lineage commitment, resulting in emergence of dual identity lymphocytes in mice and humans.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 05, 2026

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodies.

Journal: medRxiv : the preprint server for health sciences
Published: April 10, 2026

FcγRIIB functions as an IgG transporter in the mammary gland.

FcγRIIB functions as an IgG transporter in the mammary gland.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 28, 2026

Re-evaluation of the contribution of TNFRSF13B variants to antibody deficiency.

Re-evaluation of the contribution of TNFRSF13B variants to antibody deficiency.

Journal: Journal of human immunity
Published: September 17, 2025

A Response to the Letter to the Editor: Refining Risk and Redefining Stage: Hidden Implications of BAP1-Mutant Mesothelioma Shiuan-Chih Chen, MD, PhD; Yuan-Ti Lee, MD, PhD.

A Response to the Letter to the Editor: Refining Risk and Redefining Stage: Hidden Implications of BAP1-Mutant Mesothelioma Shiuan-Chih Chen, MD, PhD; Yuan-Ti Lee, MD, PhD.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 18, 2025

Systematic functional validation of IKAROS variants from patients and laboratory-generated mutations.

Systematic functional validation of IKAROS variants from patients and laboratory-generated mutations.

Journal: Blood advances
Published: May 23, 2025

Systematic functional validation of IKAROS variants from patients and laboratory-generated mutations.

Systematic functional validation of IKAROS variants from patients and laboratory-generated mutations.

Journal: Blood advances
Published: May 23, 2025

Clinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations.

Clinical and Pathologic Phenotyping of Mesotheliomas Developing in Carriers of Germline BAP1 Mutations.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 18, 2025

Monoallelic expression in human immune cells: linking genotype to phenotype.

Monoallelic expression in human immune cells: linking genotype to phenotype.

Journal: Trends in immunology
Published: February 11, 2025

Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants.

Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants.

Journal: Journal of virology
Published: December 04, 2024
Showing 1-12 of 219

Last Updated: 09/26/2026